Net (loss) income

Name: BioCryst Pharmaceuticals Net (loss) income by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BioCryst Pharmaceuticals·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$12.67M	-$14.03M	-$26.8M	$32K	$5.09M	$12.9M	$245.85M	-$721.81M
Total	-$12.67M	-$14.03M	-$26.8M	$32K	$5.09M	$12.9M	$245.85M	-$721.81M

Business SegmentsView metric